| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Original Article
Volume 8, Number 2, February 2016, pages 126-129
Predictors of Outcome of Rectovaginal Fistula Surgery in Women With Crohn’s Disease
Table
| Characteristic | Cases (N = 16) | Controls (N = 47) | P-value |
|---|---|---|---|
| *Satterthwaite method of comparison. | |||
| BMI, median (range) | 24.9 (18.6 - 36.6) | 23.6 (18 - 70) | 0.502* |
| BMI categorical | 0.718 | ||
| Obese | 3 (21%) | 11 (25%) | |
| Overweight | 4 (29%) | 8 (18%) | |
| Standard weight | 7 (50%) | 25 (56%) | |
| Type of surgery | 0.0004* | ||
| Mucosal flap procedure | 88% | 12% | |
| Seton placement | 13% | 77% | |
| Age at surgery, median (range) | 36 (26 - 60) | 38 (18 - 78) | 0.847 |
| Age at diagnosis, median (range) | 28 (20 - 59) | 28 (12-78) | 0.908 |
| DOD, median (range) | 6 (1 - 9) | 4 (1 - 110) | 0.906 |
| Ethnicity, African American | 12 (75%) | 26 (55%) | 0.165 |
| Past RVF surgery | 8 (50%) | 20 (43%) | 0.759 |
| Smoking | 0 (0%) | 7 (15%) | 0.101 |
| Steroid use | 4 (25%) | 10 (21%) | 0.739 |
| AZA/6-MP use | 1 (6.3%) | 7 (15%) | 0.667 (Fisher) |
| Biologic use | 7 (43%) | 29 (61%) | 0.212 |
| Methotrexate use | 1 (6%) | 3 (6%) | 1.0 (Fisher) |
| EIM | 2 (13%) | 4 (9%) | 0.626 (Fisher) |
| Active clinical disease | 8 (50%) | 16 (34%) | 0.261 |
| Active colonic mucosal disease | 9 (56%) | 16 (34%) | 0.119 |
| Active rectal disease | 4 (25%) | 15 (32%) | 0.223 |